Author: admin

  • Justin Madders – 2016 Parliamentary Question to the Department of Health

    Justin Madders – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Justin Madders on 2016-06-07.

    To ask the Secretary of State for Health, who the senior leaders and board members are of the 44 Sustainability and Transformation Plan footprints.

    George Freeman

    The Sustainability and Transformation Plans (STP) leads for the footprints are as provided below. The names of other members of the footprints are held locally.

    Footprint

    STP footprint lead

    Northumberland, Tyne and Wear

    Mark Adams (Chief Officer, Newcastle Gateshead Clinical Commissioning Group (CCG))

    West, North and East Cumbria

    Stephen Eames (Chief Executive, North Cumbria University Hospitals NHS Trust)

    Durham, Darlington and Tees, Hambleton, Richmondshire and Whitby

    Alan Foster (Chief Executive, North Tees and Hartlepool NHS Foundation Trust)

    Lancashire and South Cumbria

    Dr Amanda Doyle OBE (Chief Clinical Officer, Blackpool CCG)

    West Yorkshire

    Rob Webster (Chief Executive designate, South West Yorkshire Partnership NHS Foundation Trust)

    Coast, Humber and Vale

    TBC

    Greater Manchester

    Sir Howard Bernstein (Chief Executive, Manchester City Council)

    Cheshire and Merseyside

    Louise Shepherd (Chief Executive, Alder Hey Children’s NHS Foundation Trust)

    South Yorkshire and Bassetlaw

    Sir Andrew Cash OBE (Chief Executive, Sheffield Teaching Hospitals NHS Foundation Trust)

    Kent & Medway

    Glenn Douglas (Chief Executive, Maidstone and Tunbridge Wells NHS Trust)

    Sussex and East Surrey

    Michael Wilson (Chief Executive, Surrey and Sussex Healthcare NHS Trust)

    Frimley Health

    Sir Andrew Morris (Chief Executive, Frimley Health NHS Foundation Trust)

    Surrey Heartlands

    Julia Ross (Chief Executive, North West Surrey CCG)

    Cornwall and the Isles of Scilly

    TBC

    Devon

    Angela Pedder OBE (Chief Executive, Royal Devon and Exeter NHS Foundation Trust)

    Somerset

    Dr Matthew Dolman (Chair, Somerset CCG)

    Bristol, North Somerset, South Gloucestershire

    Robert Woolley (Chief Executive, University Hospitals Bristol NHS Foundation Trust)

    Bath, Swindon and Wiltshire

    James Scott (Chief Executive, Royal United Hospitals Bath NHS Foundation Trust)

    Dorset

    Tim Goodson (Chief Officer, Dorset CCG)

    Hampshire and the Isle of Wight

    Richard Samuel (Chief Officer, Fareham and Gosport CCG, South Eastern Hampshire CCG)

    Gloucestershire

    Mary Hutton (Accountable Officer, Gloucestershire CCG)

    Buckinghamshire, Oxfordshire and Berkshire West

    David Smith (Chief Executive, Oxfordshire CCG)

    Staffordshire

    John MacDonald (Chair, University Hospitals North Midlands NHS Trust)

    Shropshire and Telford and Wrekin

    Simon Wright (Chief Executive, Shrewsbury and Telford Hospital NHS Trust)

    Derbyshire

    Gary Thompson (Chief Officer, Southern Derbyshire CCG)

    Lincolnshire

    Allan Kitt (Chief Officer, South West Lincolnshire CCG)

    Nottinghamshire

    David Pearson (Director, Adult Social Care, Nottinghamshire County Council)

    Leicester, Leicestershire and Rutland

    Toby Sanders (Accountable Officer, West Leicestershire CCG)

    The Black Country

    Andy Williams (Accountable Officer, Sandwell West Birmingham CCG)

    Birmingham and Solihull

    Mark Rogers (Chief Executive, Birmingham City Council)

    Coventry and Warwickshire

    Andy Hardy (Chief Executive, University Hospitals Coventry and Warwickshire NHS Trust)

    Herefordshire and Worcestershire

    Sarah Dugan (Chief Executive, Worcestershire Health and Care NHS Trust)

    Northamptonshire

    John Wardell (Accountable Officer, Nene CCG)

    Cambridgeshire and Peterborough

    Dr Neil Modha (Chief Clinical Officer, Cambridgeshire and Peterborough CCG)

    Norfolk and Waveney

    TBC

    Suffolk and North East Essex

    Nick Hulme (Chief Executive, Ipswich Hospital NHS Trust)

    Milton Keynes, Bedfordshire and Luton

    Pauline Philip (Chief Executive, Luton & Dunstable University Hospital NHS Foundation Trust)

    Hertfordshire and West Essex

    Beverley Flowers (Accountable Officer, East and North Hertfordshire CCG)

    Mid and South Essex

    Dr Anita Donley (Independent Chair for Mid and South Essex Success Regime from 1st April)

    North West London

    Dr Mohini Parmar (Chair, Ealing CCG)

    North Central London

    David Sloman (Chief Executive, Royal Free London NHS Foundation Trust)

    North East London

    Jane Milligan (Chief Officer, Tower Hamlets CCG)

    South East London

    Amanda Pritchard (Chief Executive, Guy’s and St Thomas’ NHS Foundation Trust)

    South West London

    Kathryn Magson (Chief Officer, Richmond CCG)

    Note: Entries that are TBC mean that no one is as of yet confirmed in position.

  • William Wragg – 2016 Parliamentary Question to the Department of Health

    William Wragg – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by William Wragg on 2016-06-07.

    To ask the Secretary of State for Health, whether he has made an assessment of the cost effectiveness of HIV PeEP if only given to a very small group of high-risk individuals.

    Jane Ellison

    The National Institute for Health and Care Excellence is developing an evidence summary on the use of Truvada for Pre-exposure prophylaxis that is expected to be published in the autumn. The evidence summary will consider the evidence for effectiveness, safety, patient factors and resource implications including cost.

  • David Burrowes – 2016 Parliamentary Question to the Department of Health

    David Burrowes – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by David Burrowes on 2016-06-07.

    To ask the Secretary of State for Health, when the NHS England Specialised Commissioning Oversight Group plans to make an announcement on the recommendations of the Clinical Priorities Advisory Group.

    George Freeman

    The Specialised Services Commissioning Committee is due to meet at the end of June 2016. The recommendations of the Clinical Priorities Advisory Group will be announced after that meeting.

  • William Wragg – 2016 Parliamentary Question to the Department of Health

    William Wragg – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by William Wragg on 2016-06-07.

    To ask the Secretary of State for Health, if he will give NHS England the power to commission HIV PeEP through the NHS public health functions agreement known as Section 7a; and if he will make a statement.

    Jane Ellison

    Work on pre-exposure prophylaxis (PrEP) is on-going and the National Institute for Health and Care Excellence (NICE) has been asked to conduct an evidence review of Truvada for PrEP in groups at high risk of HIV. The NICE evidence summary will run alongside a pilot programme that will see £2 million invested over the next two years to target those at highest risk of HIV. This evidence review and pilot programme signifies the next steps forward and will inform any subsequent decisions about commissioning.

  • Justin Madders – 2016 Parliamentary Question to the Department of Health

    Justin Madders – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Justin Madders on 2016-06-07.

    To ask the Secretary of State for Health, whether members of the public will have a right to attend Sustainability and Transformation Plan board meetings.

    George Freeman

    We have made clear that the on-going engagement of patients and the public is part of good planning. However the Sustainability and Transformation Plans (STPs) are not statutory boards. Rather they are meetings attended by representatives of the wider health system, and are not required to meet in public as are formal boards.

    The local, statutory architecture for health and care remains. As such, the local governance for STPs will ultimately be through individual organisations. Public access to Board meetings of their local organisations will be unchanged.

  • Justin Madders – 2016 Parliamentary Question to the Department of Health

    Justin Madders – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Justin Madders on 2016-06-07.

    To ask the Secretary of State for Health, what the legal status of a Sustainability and Transformation Plan will be.

    George Freeman

    The Sustainability and Transformation Plans (STP) has no legal basis. Any plans submitted will be proposals that will form the basis for discussion. Depending on the level of local and national agreement, they may form the basis for further plans and actions that will be subject to the same legal and best practice requirements that govern the National Health Service.

    The local, statutory architecture for health and care remains, as do the existing accountabilities for Chief Executives of provider organisations and Accountable Officers of clinical commissioning groups. Organisations are still accountable for their individual organisational plans, which should form part of the first year of their footprint’s STP.

    The June STP submissions will be work-in-progress, and as such we do not anticipate the requirement for formal approval from boards and/or consultation at this early stage. Plans have no status until they are agreed. When plans are ready, normal rules around engagement and public consultation will apply.

  • Justin Madders – 2016 Parliamentary Question to the Department of Health

    Justin Madders – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Justin Madders on 2016-06-07.

    To ask the Secretary of State for Health, what proportion of Sustainability and Transformation Plans have been submitted to his Department; and what the deadline is for such plans to be submitted.

    George Freeman

    No Sustainability and Transformation Plans have been submitted yet. Draft submissions will be made to the national arm’s length bodies and are due on 30 June 2016. These documents will be discussed with footprints in July 2016.

    Plans will have no status until they are agreed. Footprints are at different starting points, and so the degree of detail that will be provided by 30 June 2016 will vary. Therefore, rather than expecting to have one ‘sign-off’ moment for all 44 plans, it is anticipated that this will occur in a series of waves over the coming weeks and months, with those areas who are more advanced achieving earlier sign off than those who will require more work.

  • Paul Farrelly – 2016 Parliamentary Question to the Department of Health

    Paul Farrelly – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Paul Farrelly on 2016-06-07.

    To ask the Secretary of State for Health, what assessment he has made of whether the Government is on target to eliminate avoidable blindness by 2020.

    Alistair Burt

    The indicator within the Public Health Outcomes Framework brings together the range of information on levels of preventable sight loss in a single place.

    The indicator is made up of four sub-indicators which are measuring the crude rates of Age-Related Macular Degeneration, glaucoma and diabetic retinopathy, and of the rate of sight loss certifications per 100,000 population.

    The latest data published by the Public Health Outcomes framework show that there were the following new certifications of visual impairment in 2013/14:

    – 11,055 for age related macular degeneration, a decrease of 90 from 2012/13;

    – 3,432 for glaucoma, an increase of 141 from 2012/13;

    – 1,563 for diabetic eye disease, a decrease of 29 from 2012/13; and

    – 22,911 overall new certifications (all causes), an increase of 264 from 2012/13.

    Early detection is essential to tackling preventable sight loss. A range of treatment and services are in place in the National Health Service to deal with the key causes of preventable sight loss.

  • Charlotte Leslie – 2016 Parliamentary Question to the Department of Health

    Charlotte Leslie – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Charlotte Leslie on 2016-06-07.

    To ask the Secretary of State for Health, what data his Department holds on adjusted mortality in care homes managed by each major provider.

    Alistair Burt

    The Department does not hold information centrally on adjusted mortality in care homes managed by each major provider.

  • Ruth Cadbury – 2016 Parliamentary Question to the Department of Health

    Ruth Cadbury – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Ruth Cadbury on 2016-06-07.

    To ask the Secretary of State for Health, what recent discussions he has had on (a) ending the role of GPs in (i) assessing eligibility for bus passes, parking badges, housing and gym membership and (ii) other non-NHS work and (b) ensuring that such work is commissioned from other sources by the requesting organisation.

    Alistair Burt

    General practitioners (GPs) are independent contractors who hold contracts with NHS England to provide primary medical services for the National Health Service. Under the terms of their contract, GPs are required to provide certain medical reports or complete certain forms, such as those required to support a claim for incapacity benefit, free of charge to their registered patients.

    Outside of contractual requirements, GPs also provide a variety of other services which successive governments have regarded as private matters between the patient and the GP providing these services. Whether or not to provide these services is a matter for individual GPs. They may decline to provide them or charge a fee for doing so. Where GPs intend to charge for services to patients, the British Medical Association advises them to forewarn patients, at the earliest opportunity, of the likely level of fees.